// App-Quantinova.ai

2701 : Botulinum Toxin in the Management of Raynaud’s Phenomenon

Researchers

Presenter

  • Zareen Ahmad

Principal Investigators

  • Keshini Devakandan

  • Melanie A Anderson

  • Sindhu Johnson

Medical Centers

  • Toronto Scleroderma Program, Mount Sinai Hospital, Toronto Western Hospital, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Toronto Scleroderma Program, Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

  • University Health Network - Toronto Western Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Botox

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved